APA (7th ed.) Citation

Sasatsu, S., Ono, Y., Miyashita, D., Yoshihara, T., Tanaka, K., Owada, S., . . . Yoshino, O. The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation: A retrospective study. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Sasatsu, Satoko, et al. The Effectiveness of an Oral Gonadotropin-releasing Hormone Antagonist Relugolix for Retained Products of Conception (RPOC) Formed After Abortion at Less than 22 Weeks of Gestation: A Retrospective Study. Frontiers Media S.A.

MLA (9th ed.) Citation

Sasatsu, Satoko, et al. The Effectiveness of an Oral Gonadotropin-releasing Hormone Antagonist Relugolix for Retained Products of Conception (RPOC) Formed After Abortion at Less than 22 Weeks of Gestation: A Retrospective Study. Frontiers Media S.A.